The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Vinnikova M.A.

Sechenov First Moscow State Medical University (Sechenov University);
Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare

Severtsev V.V.

Sechenov First Moscow State Medical University (Sechenov University);
Scientific and Practical Toxicology Center Federal Medical and Biological Agency of Russia

Risk factors for the development of psychotic disorders associated with synthetic cathinones usage

Authors:

Vinnikova M.A., Severtsev V.V.

More about the authors

Read: 2268 times


To cite this article:

Vinnikova MA, Severtsev VV. Risk factors for the development of psychotic disorders associated with synthetic cathinones usage. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(5):153‑159. (In Russ.)
https://doi.org/10.17116/jnevro2023123051153

References:

  1. Flückiger FA, Gerock JE. Contributions to the Knowledge of Catha Leaves. Butler & Tanner; 1885.
  2. Valente MJ, Guedes de Pinho P, de Lourdes Bastos M, et al. Khat and synthetic cathinones: a review. Archives of Toxicology. 2014;88(1):15-45.  https://doi.org/10.1007/s00204-013-1163-9
  3. European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2019: Trends and Developments; 2019. https://doi.org/10.2810/191370
  4. European Monitoring Centre for Drugs and Drug Addiction. Annual Report 2011: The State of the Drugs Problem in Europe; 2011. https://doi.org/10.2810/44330
  5. Centers for Disease Control and Prevention. Emergency department visits after use of a drug sold as» bath salts». Michigan, November 13, 2010-March 31, 2011. MMWR. Morbidity and Mortality Weekly Report. 2011;60(19):624-627. 
  6. Karila L, Megarbane B, Cottencin O, Lejoyeux M. Synthetic Cathinones: A New Public Health Problem. Current Neuropharmacology. 2015;13(1):12-20.  https://doi.org/10.2174/1570159X13666141210224137
  7. Fujita Y, Koeda A, Fujino Y, et al. Clinical and toxicological findings of acute intoxication with synthetic cannabinoids and cathinones. Acute Medicine & Surgery. 2016;3(3):230-236.  https://doi.org/10.1002/ams2.182
  8. Asadullin AR, Ahmetova JeA, Nenast’eva AJu. Cathinones. A new reality. Narkologija. 2017;181(1):87-92. (In Russ.).
  9. Schifano F, Napoletano F, Chiappini S, et al. New/emerging psychoactive substances and associated psychopathological consequences. Psychological Medicine. 2021;51(1):30-42.  https://doi.org/10.1017/S0033291719001727
  10. Dubatova IV, Stoyakin IV, Karnaukh KA, Safronenko AV. Analysis of clinical manifestations and features of therapy of psychotic disorders in consumers of designer drugs. Glavnyi Vrach Yuga Rossii. 2018;59(1):52-56. (In Russ.).
  11. Kinkulkina MA, Vinnikova MA, Severtsev VV. Psychotic disorders associated with the use of synthetic cathinones: a review of the literature. Narkologia [Narcology]. 2021;20(7):52-60. (In Russ.).
  12. Orsolini L, Chiappini S, Papanti D. et al. The Bridge Between Classical and «Synthetic»/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective. Frontiers in Psychiatry. 2019;10:1-28.  https://doi.org/10.3389/fpsyt.2019.00851
  13. Antonowicz JL, Metzger AK, Ramanujam SL. Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: Two cases. General Hospital Psychiatry. 2011;33(6):640.e5-640.e6.  https://doi.org/10.1016/j.genhosppsych.2011.04.010
  14. Vallersnes OM, Dines AM, Wood DM, et al. Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry. 2016;16(1):293.  https://doi.org/10.1186/s12888-016-1002-7
  15. Akiyama K, Saito A, Shimoda K. Chronic methamphetamine psychosis after long-term abstinence in Japanese incarcerated patients. The American Journal on Addictions. 2011;20(3):240-249.  https://doi.org/10.1111/J.1521-0391.2011.00124.X
  16. Arunogiri S, Gao CX, Lloyd B, Smith K, Lubman DI. The role of methamphetamines in psychosis-related ambulance presentations. The Australian and New Zealand Journal of Psychiatry. 2015;49(10):939-940.  https://doi.org/10.1177/0004867415585323
  17. Arunogiri S, Petrie M, Sharkey M, Lubman DI. Key differences in treatment-seeking stimulant users attending a specialised treatment service: a means of early intervention? Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists. 2017;25(3):246-249.  https://doi.org/10.1177/1039856216684737
  18. Chen CK, Lin SK, Huang MC, et al. Analysis of association of clinical correlates and 5-HTTLPR polymorphism with suicidal behavior among Chinese methamphetamine abusers. Chinese methamphetamine abusers. Psychiatry and Clinical Neurosciences. 2007;61(5):479-486.  https://doi.org/10.1111/J.1440-1819.2007.01696.X
  19. Beck O, Franzen L, Bäckberg M, Signell P, Helander A. Intoxications involving MDPV in Sweden during 2010—2014: Results from the STRIDA project. Clinical Toxicology (Philadelphia, Pa.). 2015;53(9):865-873.  https://doi.org/10.3109/15563650.2015.1089576
  20. Beck O, Franzén L, Bäckberg M, et al. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project. Clinical Toxicology (Philadelphia, Pa.). 2016;54(7):568-575.  https://doi.org/10.1080/15563650.2016.1190979
  21. Bramness JG, Rognli EB. Psychosis induced by amphetamines. Current Opinion in Psychiatry. 2016;29(4):236-241.  https://doi.org/10.1097/YCO.0000000000000254
  22. Wisdom JP, Manuel JI, Drake RE. Substance Use Disorder Among People With First-Episode Psychosis: A Systematic Review of Course and Treatment. Psychiatric Services (Washington, D.C.). 2011;62(9):1007. https://doi.org/10.1176/APPI.PS.62.9.1007
  • Falls in elderly and senile patients. Federation Health Ministry Clinical recommendations. 2020. (In Russ.). https://cr.rosminzdrav.ru/#!/recomend/1030
  • Chronic pain in elderly and senile patients. Russian Federation Health Ministry Clinical recommendations. 2020. (In Russ.). https://cr.rosminzdrav.ru/#!/recomend/1033
  • Clinical recommendations of the Ministry of Health of Russia «Gonarthrosis». 2021. (In Russ.). https://cr.minzdrav.gov.ru/recomend/667_1
  • Clinical recommendations of the Ministry of Health of Russia «Coxarthrosis». 2021. (In Russ.). https://cr.minzdrav.gov.ru/recomend/666_1
  • Iovu M, Dumais G, du Souich P. Anti-inflammatory activity of chondroitin sulfate. Osteoart Cart. 2008;16 Suppl 3:S14-18.  https://doi.org/10.1016/j.joca.2008.06.008
  • Du Souich P, Garcia A,Verges J, Montell E. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med. 2009;3(8A):1451-1463. https://doi.org/10.1111/j.1582-4934.2009.00826.x
  • de Abajo F, Gil M, Garcia Poza P, et al. Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study. Pharmacoepidemiol Drug Saf. 2014;23:1128-1138. https://doi.org/10.1002/pds.3617
  • King D, Xiang J. Glucosamine/Chondroitin and Mortality in a US NHANES Cohort. J Am Board Fam Med. 2020;33(6):842-847.  https://doi.org/10.3122/jabfm.2020.06.200110
  • Bell G, Kantor E, Lampe J, et al. Use of glucosamine and chondroitin in relation to mortality. Eur J Epidemiol. 2012;27(8):593-603.  https://doi.org/10.1007/s10654-012-9714-6
  • Morrison L. Reduction of ischemic coronary heart disease by chondroitin sulfate. Angiology. 1971;22(3):165-174.  https://doi.org/10.1177/000331977102200308
  • Morrison L, Enrick N. Coronary Heart Disease: Reduction of Death Rate By Chondroitin Sulfate. Angiology. 1973;24(5):269-287.  https://doi.org/10.1177/000331977302400503
  • Nakazawa K, Murata K. Comparative study of the effects of chondroitin sulfate isomers on atherosclerotic subjects. Clinical Trial. Z Alternsforsch. 1979;34(2):153-159. 
  • Mazzucchelli R, Rodrı´guez-Martı´n S, Garcı´a-Vadillo A, et al. Risk of acute myocardial infarction among new users of chondroitin sulfate: A nested case-control study. PLoS ONE. 2021;16(7):e0253932. https://doi.org/10.1371/journal.pone.0253932
  • Melgar-Lesmes P, Sánchez-Herrero A, Lozano-Juan F, et al. Chondroitin Sulphate Attenuates Atherosclerosis in ApoE Knockout Mice Involving Cellular Regulation of the Inflammatory Response. Thromb. Haemost. 2018;118(7):1329-1339. https://doi.org/10.1055/s-0038-1657753
  • Williams K, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 1995;15(5):551-561.  https://doi.org/10.1161/01.atv.15.5.551
  • Adhikara I, Yagi K, Mayasari D, et al. Chondroitin Sulfate Nacetylgalactosaminyltransferase-2 Impacts Foam Cell Formation and Atherosclerosis by Altering Macrophage Glycosaminoglycan Chain. Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):1076-1091. https://doi.org/10.1161/ATVBAHA.120.315789
  • Bell J, Rhind S, Di Battista A, et al. Biomarkers of glycocalyx injury are associated with delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage: a case series supporting a new hypothesis. Neurocrit Care. 2016;26(3):339-347.  https://doi.org/10.1007/s12028-016-0357-4
  • Nuytemansa K, Ortelb T, Gomeza L, et al. Variants in chondroitin sulfate metabolism genes in thrombotic storm. Thromb Res. 2018;161:43-51.  https://doi.org/10.1016/j.thromres.2017.11.016
  • Ye J, Esmon C, Johnson A. The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin. J Biol Chem. 1993;268(4):2373-2379.
  • McGee M, Wagner W. Chondroitin Sulfate Anticoagulant Activity Is Linked to Water Transfer Relevance to Proteoglycan Structure in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2003;23(10):1921-1927. https://doi.org/10.1161/01.ATV.0000090673.96120.67
  • Moroudas A, Weinberg P, Parker K, Winlove C. The distribution and diffusion of small ions in chondroitin sulfate, hyaluronate and some proteoglycans solutions. Biophys Chem. 1988;32(2-3):257-270.  https://doi.org/10.1016/0301-4622(88)87012-1
  • Email Confirmation

    An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

    Email Confirmation

    We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.